These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3063854)

  • 1. [Urotoxicity of enocitabine (BH-AC) and aclarubicin (ACM) in pediatric patients with hematological malignancies].
    Fujiwara F; Yoshihara T; Ikushima S; Esumi N; Todo S; Morioka Y; Imashuku S; Okano S; Hashida T; Ishii T
    Rinsho Ketsueki; 1988 Sep; 29(9):1388-93. PubMed ID: 3063854
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aclacinomycin A and behenoyl ara-C combination chemotherapy for untreated acute non-lymphocytic leukemia].
    Sampi K; Honda T; Hayashi Y; Hattori M
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2211-6. PubMed ID: 6578705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [BH-AC.AMP protocol in the treatment of refractory childhood acute leukemia].
    Nakadate H; Hatayama Y; Hatae Y; Takeda T
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2907-10. PubMed ID: 3178240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute pancreatitis during the treatment of BH-AC AMP regimen for acute non-lymphocytic leukemia].
    Onozawa Y; Yahara Y; Imai Y; Kawaguchi K; Higashidani M; Yoshida M
    Rinsho Ketsueki; 1984 Nov; 25(11):1766-71. PubMed ID: 6543456
    [No Abstract]   [Full Text] [Related]  

  • 5. Aclacinomycin A and behenoyl arabinofuranosylcytosine combination chemotherapy for previously untreated acute leukemia.
    Sampi K; Sakurai M; Kaneko Y; Hattori M
    Oncology; 1986; 43(1):18-22. PubMed ID: 3455751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of therapy-related acute myeloid leukemia occurring in elderly non-Hodgkin lymphoma patients with low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor.
    Tatetsu H; Matsuno F; Takatsu N; Miyake H; Hoshino K; Nosaka K; Horikawa K; Hata H; Mitsuya H; Asou N
    Leuk Res; 2009 Jan; 33(1):197-200. PubMed ID: 18472159
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic effects of peripheral blood stem cell transplantation following combination chemotherapy using ranimustine, cytarabine, etoposide and cyclophosphamide for patients with hematological malignancies].
    Yamane T; Ohta T; Kou KR; Hashimoto S; Takekawa K; Hirai N; Tanaka K; Hasuike T; Hirai M; Ohta K
    Gan To Kagaku Ryoho; 1994 May; 21(6):903-6. PubMed ID: 7910450
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of refractory acute lymphocytic leukemia in childhood with BH-AC, ACM, 6-MP, and prednisolone].
    Karube T; Maehara M; Ijima H; Muchi H
    Rinsho Ketsueki; 1984 May; 25(5):613-8. PubMed ID: 6590894
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of malignant lymphoma with single administration of BH-AC (N4-behenoyl-1-beta-D-arabinofuranosylcytosine].
    Oguro M; Takagi T
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):508-15. PubMed ID: 6764108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction chemotherapy with idarubicin plus N4-behenoyl-1-beta-D-arabinofuranosylcytosine in acute myelogenous leukemia: a newly designed induction regimen--a prospective, cooperative multicenter study.
    Park HS; Kim DW; Kim CC; Kim HK; Kim JS; Hwang TJ; Kim HJ; Kim HS; Song HS; Park JW; Ahn HS; Chung TJ; Cho KS; Lee KS; Choi YM
    Semin Hematol; 1996 Oct; 33(4 Suppl 3):24-9. PubMed ID: 8916313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mucosal injury of aclacinomycin A in patients with adult acute leukemia--comparison of BH-AC. AMP therapy and BH-AC. DMP therapy].
    Takeyama H; Kataoka T; Yano K; Fukutani H; Watanabe E
    Rinsho Ketsueki; 1986 Apr; 27(4):508-13. PubMed ID: 3461186
    [No Abstract]   [Full Text] [Related]  

  • 12. [Etoposide (VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia].
    Esumi N; Todo S; Arakawa S; Imashuku S
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):951-8. PubMed ID: 3963859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gastrointestinal symptoms of aclacinomycin A in patients with adult acute nonlymphocytic leukemia--comparison of BH-AC-DMP therapy and BH-AC-AMP therapy].
    Kawano F; Tajima H; Matsuoka Y; Asou N; Takatsuki K
    Rinsho Ketsueki; 1985 Apr; 26(4):494-8. PubMed ID: 3862889
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase I trial of cytarabine and hydroxyurea.
    Pfeifle CE; Howell SB
    Cancer Treat Rep; 1983 Dec; 67(12):1127-9. PubMed ID: 6652629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Remission induction by ACM-A and BH-AC on acute promyelocytic leukemia which is resistant to DNR and CA (author's transl)].
    Shimazaki C; Nakajima Y; Ura Y; Hamami T; Haruyama H; Isemura T; Nakagawa M; Ijichi H
    Rinsho Ketsueki; 1981 Jul; 22(7):1116-22. PubMed ID: 6948970
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acute lymphoblastic leukemia in childhood. A 10-year experience with the DFCI 81-01 protocol].
    de Lacerda AF; Chagas M; Neto A; Vieira E; Ribeiro MJ; Pereira F; Ambrósio A; Sousinha M
    Acta Med Port; 1999; 12(7-11):287-92. PubMed ID: 10707467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials refferal resource. Current clinical trials of new agents and novel therapies in pediatric leukemia and lymphoma.
    Smith MA; Schoenfeldt M
    Oncology (Williston Park); 2003 Oct; 17(10):1377, 1380, 1383-4. PubMed ID: 14606363
    [No Abstract]   [Full Text] [Related]  

  • 18. [ABEP chemotherapy in the treatment of advanced non-Hodgkin's lymphomas].
    Yoshida T; Nakanishi J; Ito K; Kobayashi K; Ohtake S; Nakamura S; Matsuda T; Nakagoshi T; Natori K; Nakamura E
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):984-9. PubMed ID: 3963862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New agents in the treatment of leukemia and lymphoma].
    Yamada K
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1031-40. PubMed ID: 6347079
    [No Abstract]   [Full Text] [Related]  

  • 20. Isolated central nervous system relapse in acute lymphocytic leukemia (ALL) in children. Experiences of the Swiss Pediatric Oncology Group (SPOG/SAKK) 1976-1986.
    Stucki F; Arnet B; Baumgartner C; Beck D; Berchtold W; Bertrand AM; Bleher EA; Caflisch U; Delaleu B; Feldges A
    Helv Paediatr Acta; 1988 Nov; 43(3):187-93. PubMed ID: 3065299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.